Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143154 · ClinicalTrials.gov registry record
Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis
A clinical trial of GBS Positive and Women in Labor Given Vancomycin for Prophylaxis, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- 77
- Enrollment target
- 1
- Study location
NCT02143154: Completed study of GBS Positive and Women in Labor Given Vancomycin for Prophylaxis, sponsored by Women and Infants Hospital of Rhode Island.
NCT02143154 is a study of GBS Positive and Women in Labor Given Vancomycin for Prophylaxis that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 77 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02143154, a study of GBS Positive and Women in Labor Given Vancomycin for Prophylaxis, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
While it is clear that intrapartum antibiotics reduce neonatal GBS infection rates, the mechanism by which these drugs prevent neonatal GBS is not well established. One postulated theory is antibiotics work to reduce bacterial load in the birth canal; thus decreasing fetal exposure during labor and delivery. To our knowledge, the relationship between vancomycin and vaginal GBS colony counts has never been studied. In this prospective cohort study, our objective is to determine the relationship between intrapartum IV vancomycin and vaginal GBS colony counts.
Conditions Studied
Study Locations (1)
Rhode Island
- Women & Infants Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-10-03 |
What the finished NCT02143154 record still lists
NCT02143154 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 2 conditions, with GBS Positive appearing as the primary indexed condition, and to 0 interventions.
NCT02143154 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02143154 about?
NCT02143154 is a clinical study titled "Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis". While it is clear that intrapartum antibiotics reduce neonatal GBS infection rates, the mechanism by which these drugs prevent neonatal GBS is not well established. One postulated theory is antibiotics work to reduce bacterial load in the birth canal; thus decreasing fetal exposure during labor and ...
What is the current status of trial NCT02143154?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2014-10. Estimated completion is 2018-10-03.
What conditions does trial NCT02143154 study?
This clinical trial studies the following conditions: GBS Positive, Women in Labor Given Vancomycin for Prophylaxis.
Who is sponsoring clinical trial NCT02143154?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02143154 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia